Pharmaceutical

Volrustomig by AstraZeneca for Cervical Cancer: Likelihood of Approval

Volrustomig is under clinical development by AstraZeneca and currently in Phase III for Cervical Cancer.

Dec 22, 2023 - 18:00
Volrustomig is under clinical development by AstraZeneca and currently in Phase III for Cervical Cancer.
Read the original article

Tags:

Previous Article

IBI-322 by Innovent Biologics for Lymphoma: Likelihood of Approval

Next Article

Runimotamab by Genentech USA for Solid Tumor: Likelihood of Approval

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: Medicare taps acting official to head up its new drug price negotiations

STAT+: Medicare taps acting official to head up its new...

Jun 6, 2023

BlossomHill secures $100m for cancer discovery programmes 

BlossomHill secures $100m for cancer discovery programmes 

Mar 1, 2024

STAT+: Alarmed by popularity of Ozempic and Wegovy, insurers wage multi-front battle

STAT+: Alarmed by popularity of Ozempic and Wegovy, ins...

Aug 3, 2023